BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4588974)

  • 1. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled study on the effect of a new substance in peripheral arterial diseases].
    Poti R; Megha A; Pini M; Bulletti G
    Minerva Cardioangiol; 1974; 22(7-8):574-87. PubMed ID: 4605589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with Dilangio in patients with reflex sympathetic algodystrophia of the extremities].
    Velasco Domínguez E
    Rev Esp Reum Enferm Osteoartic; 1974; 17(3):200-11. PubMed ID: 4438804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of peripheral circulation disorders with 1-benzyl-1-(3-dimethyl-amino-propoxy)-cycloheptane].
    Denck H
    Wien Med Wochenschr; 1973 Mar; 123(11):174-8. PubMed ID: 4692075
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of thrombocyte adhesion by bencyclane: experimental and clinical results.
    Martin M; Schäfer G; Martin U; Juraschek H; Knüll W
    Thromb Res; 1974 Jun; 4(6):741-52. PubMed ID: 4844058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of peripheral circulation disorders. Double-blind study on the effect of fludilat].
    König FK
    Med Welt; 1972 May; 23(20):763-8. PubMed ID: 5037194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G; Trübestein R; Ludwig M
    Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].
    Krähenbühl B
    Schweiz Rundsch Med Prax; 1975 May; 64(20):632-4. PubMed ID: 1099573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind study on piribedil in peripheral arterial diseases].
    Milliken JC; Fares CM; O'Connor D
    Minerva Med; 1976 May; 67(25):1662-7. PubMed ID: 778668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM; Lepore R
    Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.